Outcomes of Colonoscopy With Non-anesthesiologist Administered Propofol
- Conditions
- ADRColo-rectal CancerColon Adenoma
- Interventions
- Procedure: Sedation directed by an anesthesiologistProcedure: Sedation directed by an endoscopist
- Registration Number
- NCT03922074
- Lead Sponsor
- Serveis de Salut Integrats Baix Empordà
- Brief Summary
The Efficacy and safety of Non-anesthesiologist administered propofol (NAAP) for gastrointestinal endoscopy have been widely documented although there is not information which has evaluated the outcomes of colonoscopy it self when the endoscopist has to fulfill the additional task of supervising the sedation.
Objective: To determine the equivalence of adenoma detection rate (ADR) in colorectal cancer (CRC) screening colonoscopies performed with NAAP and performed with monitored anesthesia care (MAC).
Method: Single blind non-randomized controlled equivalence trial. Patients: Adults between 50 - 69 years old from National CRC screening program (CRCSP). Intervention: The patients are blindly assigned to undergo either colonoscopy with NAAP or MAC according to the arrival of fecal occult blood test, patient's suitability for colonoscopy date and availability of places at endoscopy schedule (with NAAP or MAC).
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 630
Healthy patients -
Patients with familial colorectal cancer history
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description Monitored anesthesia care Sedation directed by an anesthesiologist Sedation directed by an anesthesiologist in which the used intravenous drugs and target level sedation are chosen by the anesthesiologist. Non-anesthesiologist administered propofol Sedation directed by an endoscopist Sedation directed by an endoscopist in which the intravenous drugs are propofol and fentanyl . Target level sedation: moderate - deep.
- Primary Outcome Measures
Name Time Method Adenoma detection rate 30 days Percentage of patients aged ≥50 years undergoing first-time screening colonoscopy who have one or more conventional adenomas detected and removed
- Secondary Outcome Measures
Name Time Method